MIM
PRVL

MetLife Investment Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

MetLife Investment Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,723
Closed -$155K – 2356
2020
Q4 		$155K Buy
+6,723
New +$155K ﹤0.01% 2113
2020
Q3 		– Sell
-7,148
Closed -$107K – 2351
2020
Q2 		$107K Hold
7,148
– – ﹤0.01% 2225
2020
Q1 		$87.1K Buy
+7,148
New +$87.1K ﹤0.01% 2150